Drug Trial Radar · NCT00036166
Study of FK463 for the Treatment of Invasive Aspergillosis
Last checked: Nov 19, 2026Latest source record: Jan 10, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
326
Actual
Start
Jan 29, 1999
Primary completion
Jan 31, 2002
Study completion Jan 31, 2002
Sponsor
- Lead sponsor
- Astellas Pharma IncAstellas (ALPMY)
- Sponsor type
- Industry
- First posted
- May 9, 2002
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the safety and efficacy of FK463 in patients with proven or probable invasive infections due to Aspergillus species.
Conditions
- Aspergillosis
Interventions
FK463Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
23 sites in 8 countries. Site status is shown where the registry gives one.
Medizinische Univ.-Klinik
Graz, Austria
Krankenhaus Elisabethinen Linz
Linz, Austria
Hopital Henri Mondor, Service d'Hematologie Clinique
Créteil, France
Hotel Dieu, Service d'Hematologie
Nantes, France
Hopital Saint Louis, Service D'Hematologie/Greffe de Moelle
Paris, France
Hopital Necker Enfants Malades, Service d'Hematologie
Paris, France
Johann Wolfgang Goethe Universitat, Medizinische Klinik III
Frankfurt, Germany
Westpfalz Krankehaus
Kaiserslautern, Germany
Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie
Leipzig, Germany
Klinikum der Stadt, Medizinische Klinik A
Ludwigshafen, Germany
Uniklinik Mainz
Mainz, Germany
LMU Munchen, Hamatopoetische Zell - Transplantation
München, Germany
Universitat Wurzburg, Institut fur Molekulare und Infectionsbiologie
Würzburg, Germany
Nationale Institute for Cancer Research
Genova, Italy
Ospedale Niguarda-Ca Granda, Dept. of Internal Medicine Padiglione Brera
Milan, Italy
Institute of Haematology and Blood Transfusion
Warsaw, Poland
Hospital Clinic I provencial, Servicio Enfermadades Infecciosas
Barcelona, Spain
Hospital Gregorio Maranon, Servicio de Enfermadades Infecciosas
Madrid, Spain
Hospital Doce de Octubre, Servicio de Microbiologia y Enfermadades Infecciosas
Madrid, Spain
Huddinge University Hospital, Dept. of Transplantation Surgery/Immunology
Huddinge, Sweden
Royal Free Hospital, Dept. of Haematological Oncology
London, United Kingdom
Christie Hospital NHS Trust
Manchester, United Kingdom
Royal Marsden Hospital
Sutton Surrey, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.